Table 3.
Smaller extent of disease
|
Larger extent of disease
|
||||||
---|---|---|---|---|---|---|---|
Perpendicular | Cavity-Shave | p-value | Perpendicular | Cavity-Shave | p-value | ||
Rate of positive margins on first excision | |||||||
T1 (≤2cm) | 13% | 12% | 0.69 | T2/3 (>2cm) | 27% | 14% | 0.20 |
No EIC | 14% | 11% | 0.50 | EIC | 19% | 15% | 0.67 |
T1 and no EIC | 13% | 11% | 0.56 | T2/T3 or EIC | 23% | 15% | 0.34 |
| |||||||
Median total volume excised to achieve negative margins (ml) | |||||||
T1 (≤2cm) | 47ml | 61ml | 0.03 | T2/3 (>2cm) | 95ml | 69ml | 0.47 |
No EIC | 48ml | 63ml | 0.02 | EIC | 86ml | 55ml | 0.34 |
T1 and no EIC | 45ml | 63ml | 0.01 | T2/T3 or EIC | 86ml | 61ml | 0.14 |
T stage, American Joint Commission on Cancer tumor stage; EIC, extensive intraductal component
Note: p-values derived from linear regression models using natural logarithm of total volume to negative margins.